Theravance Falls Most in 3 Years After Glaxo Drug Fails – BusinessWeek


Visit Bulgaria

Theravance Falls Most in 3 Years After Glaxo Drug Fails
BusinessWeek
The company, based in South San Francisco, California, said in a statement today that Relovair, its drug for asthma and chronic obstructive pulmonary disease, proved no better than Glaxo's Seretide in a clinical trial. Relovair is “the most important
GSK and Theravance Announce Initial Outcomes From Pivotal Phase III Studies MarketWatch (press release)
Glaxo on the slide after trials setback for asthma drugEvening Standard
Theravance Shares Slide on Lung Drug DeathsTheStreet.com
Visit Bulgaria –Wall Street Journal (India) –FierceBiotech
all 73 news articles »

View full post on asthma – Google News

UNI student’s death spurs family to advocate awareness, education – Waterloo Cedar Falls Courier

UNI student's death spurs family to advocate awareness, education
Waterloo Cedar Falls Courier
(KEVIN E. SCHMIDT / Courier Lee News Service) Asthma is a chronic disease that may affect a person's quality of life. It causes wheezing, breathlessness, chest tightness and coughing. It can be triggered by allergies. The growing incidence of asthma in

View full post on asthma – Google News